The move will bring expertise to the organisation at a time when membership is reportedly “reaching new heights”
The Society of Hospital Pharmacists of Australia (SHPA) has announced a newly expanded Board of Directors, marking the start of what it calls “a new era” through expanded scope of practice for Australia’s leading community of hospital pharmacists, technicians and pharmacy assistants.
Professor Michael Dooley, who was re-elected as SHPA President in December 2017, welcomed David Brennan, David Butt and Lindsay Cane to the Board of Directors as new expert appointments, positions enabled by members’ support of the new SHPA Constitution in September last year.
Professor Dooley says the new Board will bring broad strategic experience and expertise at a time of strong organisational growth and a rapidly evolving pharmacy landscape.
“Not only is membership reaching new heights, but our growing suite of complementary member-driven programs is ensuring SHPA is the essential professional partner of pharmacists and technicians committed to making a difference in the challenging and complex hospital setting,” says Professor Dooley.
“SHPA is supporting members through a stronger national voice on systemic issues, renewed focus on specialty disciplines and new student initiatives, and shaping the strategic direction of the new Advancing Practice program through the Advanced Practice Collaborative.”
New to the SHPA Board of Directors in 2018:
- David Brennan, an experienced investment banking executive and company Director across financial, resources and healthcare sectors.
- Lindsay Cane brings experience as a seasoned CEO and Director to SHPA, having led national and state health agencies, sporting organisations, not-for-profit and private sector businesses.
- David Butt has 18 years’ experience as CEO and ‘many more’ as an executive across the health system, in policy, planning, purchasing and providing services, at national, state and regional levels.